NFKB1 and acute lymphoblastic leukemia: Nonetheless, Mdm2 increases p65 promoter activity by reversing p53-mediated suppression of p65 in acute lymphoblastic leukemia cells [12], so it could contribute to p53's effects on NF-κB signaling via the ubiquitin-proteasome system.